Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paloma H Giangrande

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer TherapySven Kruspe, Paloma H Giangrande
Biomedicines|August 10, 2017
Aptamer-siRNA Chimeras: Discovery, Progress, and Future ProspectsSven Kruspe, Paloma H Giangrande
Methods (San Diego, Calif.)|March 15, 2016
AFBI assay - Aptamer Fluorescence Binding and Internalization assay for cultured adherent cellsWilliam H Thiel, Paloma H Giangrande
Therapeutic Delivery|June 7, 2011
Intracellular delivery of RNA-based therapeutics using aptamersKristina W Thiel, Paloma H Giangrande
Methods (San Diego, Calif.)|October 21, 2015
Analyzing HT-SELEX data with the Galaxy Project tools--A web based bioinformatics platform for biomedical researchWilliam H Thiel, Paloma H Giangrande
Methods (San Diego, Calif.)|December 4, 2015
Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cellsDavid D Dickey, Paloma H Giangrande
Oligonucleotides|August 6, 2009
Therapeutic applications of DNA and RNA aptamersKristina W Thiel, Paloma H Giangrande
Therapeutic Delivery|December 6, 2013
Current progress on aptamer-targeted oligonucleotide therapeuticsJustin P Dassie, Paloma H Giangrande
The EMBO Journal|October 29, 2004
E2Fs link the control of G1/S and G2/M transcriptionWencheng Zhu, Paloma H Giangrande, Joseph R Nevins
Cell Cycle (Georgetown, Tex.)|May 7, 2005
Temporal control of cell cycle gene expression mediated by E2F transcription factorsWencheng Zhu, Paloma H Giangrande, Joseph R Nevins
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer TherapySven Kruspe, Paloma H Giangrande
Biomedicines|August 10, 2017
Aptamer-siRNA Chimeras: Discovery, Progress, and Future ProspectsSven Kruspe, Paloma H Giangrande
Methods (San Diego, Calif.)|March 15, 2016
AFBI assay - Aptamer Fluorescence Binding and Internalization assay for cultured adherent cellsWilliam H Thiel, Paloma H Giangrande
Therapeutic Delivery|June 7, 2011
Intracellular delivery of RNA-based therapeutics using aptamersKristina W Thiel, Paloma H Giangrande
Methods (San Diego, Calif.)|October 21, 2015
Analyzing HT-SELEX data with the Galaxy Project tools--A web based bioinformatics platform for biomedical researchWilliam H Thiel, Paloma H Giangrande
Methods (San Diego, Calif.)|December 4, 2015
Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cellsDavid D Dickey, Paloma H Giangrande
Oligonucleotides|August 6, 2009
Therapeutic applications of DNA and RNA aptamersKristina W Thiel, Paloma H Giangrande
Therapeutic Delivery|December 6, 2013
Current progress on aptamer-targeted oligonucleotide therapeuticsJustin P Dassie, Paloma H Giangrande
The EMBO Journal|October 29, 2004
E2Fs link the control of G1/S and G2/M transcriptionWencheng Zhu, Paloma H Giangrande, Joseph R Nevins
Cell Cycle (Georgetown, Tex.)|May 7, 2005
Temporal control of cell cycle gene expression mediated by E2F transcription factorsWencheng Zhu, Paloma H Giangrande, Joseph R Nevins
Pageof 7